Murine esBAF chromatin remodeling complex subunits BAF250a and Brg1 are necessary to maintain and reprogram pluripotency-specific replication timing of select replication domains by Takebayashi, Shin-ichiro et al.
 Murine esBAF chromatin remodeling complex subunits BAF250a
and Brg1 are necessary to maintain and reprogram pluripotency-
specific replication timing of select replication domains
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Takebayashi, S., I. Lei, T. Ryba, T. Sasaki, V. Dileep, D.
Battaglia, X. Gao, et al. 2013. “Murine esBAF chromatin
remodeling complex subunits BAF250a and Brg1 are necessary
to maintain and reprogram pluripotency-specific replication
timing of select replication domains.” Epigenetics & Chromatin
6 (1): 42. doi:10.1186/1756-8935-6-42.
http://dx.doi.org/10.1186/1756-8935-6-42.
Published Version doi:10.1186/1756-8935-6-42
Accessed February 19, 2015 3:14:47 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879619
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAA
Takebayashi et al. Epigenetics & Chromatin 2013, 6:42
http://www.epigeneticsandchromatin.com/content/6/1/42RESEARCH Open AccessMurine esBAF chromatin remodeling complex
subunits BAF250a and Brg1 are necessary to
maintain and reprogram pluripotency-specific
replication timing of select replication domains
Shin-ichiro Takebayashi1, Ienglam Lei2,3,4, Tyrone Ryba1, Takayo Sasaki1, Vishnu Dileep1, Dana Battaglia1,
Xiaolin Gao2,3, Peng Fang2,3, Yong Fan2,3, Miguel A Esteban5, Jiong Tang6, Gerald R Crabtree6,
Zhong Wang2,3,4 and David M Gilbert1*Abstract
Background: Cellular differentiation and reprogramming are accompanied by changes in replication timing and 3D
organization of large-scale (400 to 800 Kb) chromosomal domains (‘replication domains’), but few gene products
have been identified whose disruption affects these properties.
Results: Here we show that deletion of esBAF chromatin-remodeling complex components BAF250a and Brg1, but
not BAF53a, disrupts replication timing at specific replication domains. Also, BAF250a-deficient fibroblasts reprogrammed
to a pluripotency-like state failed to reprogram replication timing in many of these same domains. About half of the
replication domains affected by Brg1 loss were also affected by BAF250a loss, but a much larger set of domains was
affected by BAF250a loss. esBAF binding in the affected replication domains was dependent upon BAF250a but, most
affected domains did not contain genes whose transcription was affected by loss of esBAF.
Conclusions: Loss of specific esBAF complex subunits alters replication timing of select replication domains in
pluripotent cells.
Keywords: Replication domains, Replication timing, esBAF complex, Chromosome, Developmental regulationBackground
Developmental changes in chromosome structure can
occur at the level of large, often megabase-sized chromo-
some domains [1-5]. This cell type-specific chromosomal
domain structure is thought to be important for coordinat-
ing expression of genes, thereby ensuring proper develop-
ment of embryos. However, the mechanisms regulating
large-scale changes in chromosome structure during devel-
opment are poorly understood. In particular, very few gene
products have been found to be necessary to maintain
structure and function of chromosomes at this level of
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article, unless otherwise stated.The temporal order of replication (replication timing)
is linked to many basic cellular processes that are regu-
lated both during the cell cycle and development. We
have developed a simple and robust assay to measure
replication timing genome-wide [6,7]. We found that
400 to 800 Kb-sized replication domains are spatio-
temporally reorganized genome-wide during embryonic
stem (ES) cell differentiation into various cell lineages
[6,8]. Similar sized replication domains are also misregu-
lated in leukemia [9]. Cell type specific reorganization of
replication domains is generally coordinated with tran-
scriptional changes and is conserved between mouse
and human [10-12]. Replication domain reorganization
is also observed during iPSC generation in which som-
atic cell specific replication domain structure is erased
and ESC-specific replication domain structure is re-
established [8]. Considering that replication domains arentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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presumed that epigenetic mechanisms play an important
role in the formation of replication domain structure. How-
ever, in mammals, little or no effect on replication timing
regulation has been reported for many chromatin modifier
mutants, while these mutations significantly affect gene ex-
pression patterns [13-15]. Recently the first gene products
with widespread effects on global replication timing in yeast
(Fkh1/2 and Rif1) and mammals (Rif1) were identified
[16-19]. Other gene products have been shown to have
small effects on pericentric heterochromatin replication
(Sub39h1/2 and G9a) [13,14]. Finally, replication timing of
rDNA was shown to be affected by mutations in the
rDNA-specific chromatin remodeling complex NoRC [20].
Together, these results suggest that specific gene products
should eventually be identified that regulate cell type and
domain-specific affects. Inspired by the specific and dra-
matic effect of NoRC on regulation of rDNA replication
timing, we investigated the role of cell type specific chro-
matin remodeling complexes in replication timing changes
during embryonic stem cell differentiation.
Brahma-associated factor (BAF) complexes are members
of SWI/SNF ATP-dependent chromatin-remodeling family
and regulate access of transcription factors by modulating
chromatin structure. Of particular interest is that BAF
subunits undergo compositional and stoichiometric change
during mammalian development, which confers unique
and essential roles to the complexes in cell fate determin-
ation [21-24]. For example, BAF155, BAF250a, and Brg1
are highly expressed in ESCs and their expression decreases
significantly when ESCs differentiate, suggesting that these
components may be essential for keeping ESCs in the un-
differentiated ‘ground state’ [25]. In fact, Brg1 and BAF155
significantly promote reprogramming of mouse embryonic
fibroblasts (MEFs) in combination with Yamanaka factors
(Oct4, Sox2, Klf4, and c-Myc) [26]. BAF components are
also instrumental for tissue-specific differentiation. The
proper switch of neuron-specific BAF53 and BAF45 iso-
forms determines either the self-renewal or differentiation
of neuron progenitor cells [27] and can convert fibro-
blasts to neurons [28]. Ectopic expression of BAF60c, a
cardiac-enriched subunit, along with transcription fac-
tors GATA4 and TBX5, can convert non-cardiogenic
mesoderm into beating cardiomyocytes [29]. These
studies suggest that tissue-specific BAF complexes cre-
ate chromatin environments favorable for transcription
factor access.
In this study, we found that the embryonic stem cell-
specific BAF complex (esBAF) complex deficiency leads to
alterations of replication timing both in ESCs and during
cellular reprogramming. Loss of DNA binding of the
complex, but not transcriptional changes, correlated with
changes in replication timing. These findings demonstrate
the importance of chromatin remodeling complexes formaintaining replication-timing programs and, by proxy,
large-scale chromatin reorganization.
Results and discussion
BAF250a is required to maintain replication timing at
specific domains in embryonic stem cells
We first examined the effect of acute BAF250a loss on
replication timing. BAF250a is essential for early em-
bryogenesis and has shown to be involved in the recruit-
ment of esBAF to its target sites [30,31]. We generated a
cell line in which both homologues of BAF250a undergo
simultaneous conditional deletion. In these cell lines,
exon 8 of the BAF250a gene is flanked by 2 loxp sites
and Cre recombinase (Mer-Cre-Mer) is induced upon
addition of 4-hydroxytamoxfen (OHT), resulting in
frameshift mutation followed by non-sense mediated
decay. BAF250a protein level was rapidly and homoge-
neously diminished within 24 h and was undetectable
72 h after OHT treatment [see Additional file 1A].
Genome-wide replication timing analysis (Figure 1A,
[7]) identified a set of genomic regions that changed
replication timing either from early to late (EtoL) or
from late to early (LtoE) in response to BAF250a loss
after 72 h but not after 24 h (Figure 1B-D and [see
Additional file 1B-C]). Observed changes in replication
timing were highly reproducible between replicates [see
Additional file 1D]. Since the changes were not as exten-
sive as developmental changes [6,8], we calculated the P
values for replication timing changes of 10,974 200-Kb
segments, and applied a False Discovery Rate (FDR).
Using this method, 691 and 1,667 200-Kb segments were
identified as significantly changing replication timing at
a 1% and 5% FDR, respectively (Figure 1C and [see
Additional file 1E]). All affected segments examined
aligned in register to domains of differential replication
in one or more tissues during normal development
(Figure 1E) and encompassed 400 to 800 Kb genomic
segments (Figure 1F), consistent with domains whose
replication timing is normally regulated during develop-
ment [8-10]. We conclude that BAF250a is required to
maintain normal developmental control of replication
timing for a fraction of the ESC genome.
Several of the EtoL regions recapitulated developmen-
tal changes that occur during ES cell differentiation,
raising the possibility that the observed changes might
be an indirect result of cell differentiation after BAF250a
loss. Indeed, it is known that BAF complex deficiency
induces cell differentiation toward the primitive endo-
derm lineage after several rounds of cell division [30].
However, during the considerably shorter 72-h induction
period, BAF250a-disrupted ESCs retained a higher
genome-wide correlation in replication timing profile
with pluripotent cell types than differentiated cell types
(Figure 1G). For example, pluripotency-associated Dppa2/4
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Figure 1 Genome-wide replication timing analysis identifies a subset of BAF250a sensitive replication domains. (A) Flow chart of
genome-wide replication timing analysis [7]. BrdU-substituted DNA from early and late S phase cells was differentially labeled and hybridized to a
whole-genome oligonucleotide microarray. (B) Replication timing profiles from mock- and 4-hydroxytamoxifen (OHT)-treated BAF250a flox/flox
embryonic stem cells (ESCs) for chromosome 15. The signal ratio of early and late (Log2 early/late) for each probe is plotted against the chromosomal
position. Shown are loess-smoothed plots for the average of two biological replicate experiments. (C) Summary of significant early to late (EtoL) and
late to early (LtoE) switching segments in OHT-treated cells. Replication timing data were averaged into 200-Kb windows and statistical significance
was calculated between mock and OHT-treated ESCs, as described in Methods. (D) Expanded plots for exemplary regions that undergo
replication-timing switches in response to BAF250a loss are shown below. (E) BAF250a-dependent timing switching domains align to
developmental boundaries. Replication timing plots of exemplary EtoL and LtoE switching domains shown in Figure 1D (mock-red and OHT-blue) are
compared to replication timing profiles from other cell types (gray). The top table shows the percentage of EtoL and LtoE switching domains that align to
developmental boundaries. (F) Box plots show the sizes of EtoL and LtoE timing switching domains compared to non-switching domains. (G) Correlation
of replication timing datasets (Pearson’s R values).
Takebayashi et al. Epigenetics & Chromatin 2013, 6:42 Page 3 of 12
http://www.epigeneticsandchromatin.com/content/6/1/42and Rex1 domains, which rapidly become late replicating
during differentiation to every germ layer [8], retained
ESC-specific early replication [see Additional file 2].
Moreover, we did not observe significant changes in
the expression level of pluripotency-associated genes
[see Additional file 3]. Together, we conclude that mu-
tant ESCs still globally maintain an overall pluripotent
cell replication timing program at least 72 h after
OHT treatment, while specific domains require esBAF
to maintain their replication time.BAF250a is required to re-establish replication timing of
an overlapping set of select domains during somatic cell
reprogramming
To further confirm the requirement of BAF250a for
replication timing of specific domains in pluripotent
cells, we investigated whether similar replication timing
defects occur in cells reprogrammed from somatic cells
in the absence of BAF250a. First we examined the effect
of BAF250a loss on formation of iPSC-like colonies.
BAF250a flox/flox and BAF250a flox/flox Mer-Cre-Mer
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http://www.epigeneticsandchromatin.com/content/6/1/42MEFs were treated with OHT at Days 3 to 5 after
virus-mediated transduction of reprogramming factors
(Oct4, Sox2, Klf4, and c-Myc; OSKM). We observed a
significant decrease in the number of alkaline phos-
phatase (AP)-positive colonies derived from cells
expressing Mer-Cre-Mer compared to control cells
(Figure 2A and B), demonstrating that BAF250a isPartial iPSC
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Figure 2 Role of BAF250a in the regulation of replication domains
(A) Number of alkaline phosphatase (AP)-positive colonies derived from
flox/flox; Mer-Cre-Mer mouse embryonic fibroblasts (MEFs) after Oct4, Sox2, Klf4
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flox/flox and BAF250a −/−, respectively. These col-
onies, which we refer to as BAF250a flox/flox OSKM
and BAF250a −/− OSKM, were also confirmed to ex-
press high levels of ESC pluripotency markers (data
not shown).
Next we performed replication-timing analysis of
BAF250a flox/flox OSKM and BAF250a −/− OSKM
cells. Despite the fact that loss of BAF250a significantly
reduced the efficiency of AP-positive colony production,
the genome-wide replication timing profiles of three in-
dependent AP-positive BAF250a −/− OSKM clones were
almost identical to that of control BAF250a flox/flox
OSKM or other ESC lines and were clearly more similar
to pluripotent cells than to partially reprogrammed
iPSCs (piPSCs; Figure 2C and D). This result suggests
that BAF250a −/− OSKM have passed the common epi-
genetic block experienced by piPSCs [8]. Nonetheless,
BAF250a −/− OSKM cells display distinct replication
timing differences from ESCs or control OSKM cells
(Figure 2E-H). When replication timing differences in
OSKM cells are compared to those in ESCs, we
observed a conservation of BAF250a-affected domains
between ESCs and OSKM cells (Figure 2E). Indeed, we
identified a set of chromosomal domains that undergo
replication timing switching in BAF250a-deficient OSKM
cells (Figure 2F) and found that significant fraction of
these switching domains overlap with those identified in
BAF250a-deficient ESCs (Figure 2G and H). These results
confirm a role for BAF250a in replication timing regulation
of specific chromosomal domains in the pluripotent state.
Loss of Brg1, but not BAF53a, affects an overlapping set
of replication domains
Since BAF250a is a subunit of the esBAF complex in
ESCs [32], we next examined the role of two other
esBAF subunits, Brg1 (catalytic ATPase subunit) and
BAF53a (another ESC-specific subunit), in the regulation
of replication domain structures. To this end, we per-
formed genome-wide replication timing analysis in Brg1
and BAF53a conditional knockout ESC lines [33,34].
Similar to BAF250a knockouts, the overall replication
timing profiles of OHT-treated Brg1 flox/flox and
BAF53a flox/- ESCs are almost identical to that of
parental (mock-treated) ESCs, suggesting an overall
maintenance of stem-cell identity in these cells
(Figure 3A and B). This was further confirmed by the
finding that expression of Oct4 did not change in these
mutant cells [see Additional file 4]. However, we found
that loss of Brg1 induced altered replication timing
profiles in a subset of chromosomal domains with a
bias for EtoL switching (Figure 3C and D) and that
these Brg1-sensitive domains significantly overlap
with BAF250a-sensitive domains (Figure 3C and [seeAdditional file 5]). On the other hand, loss of BAF53a
did not induce any significant changes in replication
timing (Figure 3C and D). This latter result, coupled
with our previously published results with other
Cre-inducible deletions [15], confirms that the changes
in replication timing are not due to the activation of
Cre recombinase by OHT treatment.
The fraction of chromosome domains that displayed
EtoL switching in response to BAF250a loss (commonly
misregulated in BAF250a-deficient ESCs and OSKM
cells), showed a very similar tendency of replication
timing switching in Brg1 but not BAF53a mutant ESCs
(Figure 3E-F). For example, at chromosome 4 (104.5-
105.0 Mb) and chromosome 7 (82.5-83.0 Mb) domains
where the BAF250a is required for early replication in
both ESCs and OSKM cells, these domains are late repli-
cating after Brg1 loss, while they remain early replicating
in the absence of BAF53a (Figure 3F). Together, these
results demonstrate a BAF53a-independent function of
the esBAF complex is required for proper regulation of
replication timing at specific replication domains. How-
ever, the partial overlap in affected regions between Brg1
and BAF250a suggests the potential for independent
roles of each subunit or gain of function effects of each
subunit in the absence of the other.
BAF250a-dependent binding of esBAF complexes to
affected domains independent of transcriptional
regulation
Since disruption of BAF complexes have a profound ef-
fect on genome-wide transcriptional regulation in ESCs
[30,33,35], we wished to determine whether the effect of
BAF250a loss on replication timing was linked to altered
gene expression in these domains. Brg1 ChIP-seq data in
mESCs [35] revealed significant enrichment of Brg1 pro-
teins in early replicating regions of the ESC genome
(Figure 4A). We observed significant enrichment of Brg1 in
Brg1-sensitive EtoL domains compared to LtoE domains,
though this enrichment level is comparable to that seen in
unaffected early replicating (EtoE) domains (Figure 4B).
Unfortunately, several anti-BAF250a antibodies were not
of sufficient quality for chromatin immunoprecipitation
(ChIP). However, Brg1 ChIP at two of the BAF250a-
sensitive early replicating domains, 500-Kb genomic
segments on chromosome 4 (104.5-105.0 Mb) and
chromosome 7 (82.5-83.0 Mb), revealed BAF250a-
dependent Brg1 enrichment at multiple sites within these
domains (Figure 4C). It should be noted that loss of
BAF250a also impaired Brg1 enrichment at the Oct4 gene
region that retains its time of replication (EtoE) regardless
of BAF250a availability (Figure 4C and [see Additional
file 6]). Thus, esBAF is generally enriched in early replicat-
ing domains, although loss of esBAF is not sufficient to
elicit a change in replication timing at all domains.
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Figure 3 Brg1 but not BAF53a is required for the regulation of replication domains. (A) Replication timing profiles of mock- and 4-
hydroxytamoxifen (OHT)-treated Brg1 flox/flox and BAF53a flox/-, displayed as in Figure 1B. Plots for the average of two biological replicate
experiments are shown. (B) Correlation analysis between replication timing datasets (Pearson’s R values). (C) Correlation analysis of replication
timing differences (dRT). Replication timing data were averaged into 200-Kb windows and dRTs (that is, Brg1 OHT ratio - Brg1 mock ratio) were
calculated for comparisons between different groups. A substantially lower conservation of replication timing affected regions is seen between
BAF53a ESCs and BAF250a or Brg1 embryonic stem cells (ESCs) than between BAF250a and Brg1 ESCs. (D) Summary of significant early to late
(EtoL) and late to early (LtoE) switching segments in OHT-treated cells as determined in Figure 1C. (E) Box plots show the replication timing of
segments that are sensitive to BAF250a loss (false discovery rate (FDR) = 1% domains identified in Figure 2G) in various esBAF subunit
mutants. Replication timing in mutants (red) is compared to that in control counterparts (green). P values were calculated using the
Wilcoxon rank sum test. (F) Replication timing plots of exemplary EtoL switching domains. These domains undergo EtoL switching in
BAF250a and Brg1 mutants, but not in BAF53a mutant.
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http://www.epigeneticsandchromatin.com/content/6/1/42Finally, we examined the effect of esBAF disruption
on transcription of genes within the domains affected
for replication timing [35]. None of the esBAF target
genes in switching regions (0/19) was more than two-fold up- or downregulated upon Brg1 knockdown
(Brg1 KD). Genes in switching regions, regardless
of whether they were targets of esBAF binding, have
no coordination between EtoL/LtoE changes and
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Figure 4 BAF250a-dependent Brg1 enrichment in early to late (EtoL) switching domains. (A) Genome-wide relationship between Brg1
enrichment and replication timing. The x-axis shows the embryonic stem cell (ESC) replication timing data averaged in 200-Kb windows and the
y-axis shows the number of Brg1 binding sites in each corresponding window. The smoothed blue line in the plot shows the average number of
Brg1 sites per 200-Kb segment (thicker gray line shows the standard error). (B) Average number of Brg1 binding sites per 200-Kb segment that
switched EtoL or LtoE after loss of Brg1 (FDR = 1% and 5% segments from Figure 3D) and comparison to the remainder of the genome (‘non-switching’).
Based on this data, 400 to 800 Kb EtoL switching domains are thought to have 3.5 to 7.0 Brg1 binding sites. (C) BAF250a-dependent Brg1
enrichment within the EtoL domain (chr4: 104.5 to 105.0 Mb and chr7: 82.5 to 83.0 Mb from Figure 3F), revealed by Brg1 chromatin
immunoprecipitation (Brg1-ChIP). Brg1 enrichment was analyzed at multiple sites within the chr4 domain (site-1: 104654835 to 104654965,
site-2: 104668986 to 104669071, site-3: 104693231 to 104693309, site-4: 104713676 to 104713776) and chr7 domain (site-1: 82610306 to
82610419, site-2: 82647473 to 82647844, site-3: 82660145 to 82660243, site-4: 82662755 to 82662863) both in mock-treated (blue) and 4-hydroxytamoxifen
(OHT)-treated (red) BAF250a flox/flox ESCs. These are Brg1 binding sites identified by ChIP-seq [35] and their positions relative to EtoL domains are shown
under the Brg1-ChIP result. The binding of Brg1 at Oct4 and Nkx2.5 promoters was used as positive and negative controls, respectively. The Oct4 promoter
region also showed a BAF250a-dependent Brg1 binding. *P <0.05; nsP >0.1 (no significant difference). Statistical analysis was performed by a two-tailed
Student’s t-test.
Takebayashi et al. Epigenetics & Chromatin 2013, 6:42 Page 7 of 12
http://www.epigeneticsandchromatin.com/content/6/1/42
Takebayashi et al. Epigenetics & Chromatin 2013, 6:42 Page 8 of 12
http://www.epigeneticsandchromatin.com/content/6/1/42transcriptional downregulation/upregulation, respect-
ively (overall R = 0.02) (Figure 5A and B). This is con-
sistent with the hypothesis that replication timing is
associated more with transcriptional competence than
transcription per se [36] and suggests that the role of
esBAF in regulating replication timing is not a direct
transcriptional role for this complex. Taken together,
these results demonstrate that BAF250a-dependent
Brg1-containing esBAF complexes are recruited to re-
gions that require BAF250a and Brg1 for early replica-
tion in ESCs, but most of these regions do not contain
esBAF-regulated genes.
Conclusions
In summary, our data presented here reveal an unantici-
pated effect of esBAF complex disruption on replication
timing and, by proxy, higher-order chromatin folding
[10,37,38]. Yeast transcription factors Fkh1 and Fkh2 are
thought to modulate replication timing by bringing early
replication origins in close proximity in the nuclear
space independent of their transcriptional activity [16].
It is possible that the BAF complexes play a similar role
in mammalian cells, thereby promoting the formation of
an early replication domain. Indeed it has been shown
that Brg1 is involved in cell type-specific chromatin loop
formation at the beta-globin locus [39]. Interestingly,
esBAF complexes are known to interact with the nuclear
matrix protein Rif1 which has recently been identified as
global replication timing regulators [18,19,32]. Currently,
it is unclear why only a small subset of esBAF-enriched
replication domains is sensitive to esBAF complex defi-
ciency. For example, other early replicating domains har-
boring genes such as Oct4 have multiple Brg1 bindingA
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Figure 5 Replication timing changes are not associated with transc
domains in ESC (4-hydroxytamoxifen (OHT) ratio - mock ratio) were plotted aga
(ESC) (Brg1 knockdown (Brg1 KD) ratio - control green fluorescent protein knoc
Brg1-affected EtoL and LtoE domains (false discovery rate (FDR) = 1% and 5% se
(EtoE) domains.sites but maintain their early replication in the absence
of BAF250a or Brg1 [see Additional file 6]. This suggests
that there are additional mechanisms maintaining early
replication of these domains, whereas we have identified
a subset of domains at which esBAF presence has a
major effect on replication timing. This may be related
to whether or not the affected domains are capable of
switching replication timing, as none of the affected do-
mains were constitutively early replicating (Figure 1E).
Future studies are warranted to uncover the mechanism
by which BAF complexes influence replication timing
during stem cell self-renewal and differentiation.
Methods
Embryonic stem cell culture
BAF250a flox/flox; Mer-Cre-Mer ESC lines were established
from day 3.5 blastocysts obtained by crossing BAF250a
flox/+; Mer-Cre-Mer with BAF250a flox/flox and main-
tained on feeder MEFs in the presence of leukemia inhibi-
tory factor (LIF) as described previously [30]. Mer-Cre-Mer
mice were purchased from the Jackson Laboratory; Bar
Harbor, ME USA (stock number: 008463). Brg1 flox/flox;
Actin-CreER and BAF53a flox/-; Actin-CreER ESC lines
were maintained as described previously [33,34]. To gener-
ate mutant ESCs, these ESC lines were treated with 1 μM
4-hydroxytamoxifen (OHT) for 24 h and harvested 48 h
later, unless otherwise indicated. As a control, cells were
treated with ethanol.
Somatic cell reprogramming
MEF cells derived from BAF250a flox/flox; Mer-Cre-Mer
and BAF250a +/+; Mer-Cre-Mer were infected with four
reprogramming factors (Oct4, Sox2, Klf4, and c-Myc,B2
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sage 5) were cultured in 6-well dishes and about 4 ×
104 cells in each well were infected overnight with viral
supernatants freshly prepared by transfection of the
retroviral packaging Plat-E cell line (Lipofectaine 2000,
Invitrogen, Life Technologies, Carlsbad, CA, USA) con-
taining the cDNAs of the mouse reprogramming factors.
Three days after infection, cells were passaged into new
wells and tamoxifen was added for three days (Days 3 to 5)
or other time windows to ablate BAF250a. Control iPSC-
like colonies (BAF250a +/+, OHT treatment or BAF250a
flox/flox; Mer-Cre-Mer, no OHT treatment) were typically
picked 21 days after infection and iPSC-like colonies from
BAF250a flox/flox; Mer-Cre-Mer, OHT treated fibroblast
culture were typically picked 30 days post infection.
Genotyping of BAF250a was performed by PCR. We used
the primer sequences 5′-GTAATGGGAAAGCGACTAC
TGGAG-3′ and 5′-TGTTCATTTTTGTGGCGGGAG-3′,
which amplify a 632-bp fragment from the WT locus, an
812-bp fragment from the floxed locus and a 298-bp frag-
ment from the knockout locus, respectively. PCR reactions
were carried out with 40 cycles (30 sec at 94°C, 30 sec
at 59°C, 1 min at 72°C). For alkaline phosphatase (AP)
staining, culture wells containing iPSC-like colonies were
washed with PBS and cells were fixed with 4% paraformal-
dehyde in PBS for 2 min at 20°C. Fixed cells were then
rinsed twice with 0.5 ml of TBST (TBS plus 0.05% Tween-
20) and incubated with fresh AP staining solution (4.5 μl
50 mg/ml nitro blue tetrazolium, 3.5 μl 50 mg/ml 5-
bromo-4-chloro-3-indolyl phosphate in 100 mM Tris–HCl,
pH 9.5, 100 mM NaCl, 50 mM MgCl2) in the dark room at
25°C for about 15 min. Stained cells were rinsed with PBS
and kept at 4°C.
Chromatin Immunoprecipitation
ChIP was performed as previously described [41]. Two
million cells were harvested and fixed in 1% formalde-
hyde for 10 min at 25°C, then stop fixation in 0.125 M
glycine. Fixed cells were sonicated to produce chromatin
fragments 300 to 700 bp in length. Chromatin fragments
were then immunoprecipitated with anti-Brg1 antibody
[42]. The precipitated DNAs were then purified by
ethanol precipitation after phenol-chloroform extraction.
Quantitative PCR reactions were performed to detect
the occupancy of Brg1 at multiple sites within the
chromosome 4 and 7 EtoL domains. Quantitative PCR
reactions included the following: 4 μl of ChIP product
(200 μl per ChIP assay), 10 μl of 2X SYBR green PCR
master mix (Applied Biosystem, Carlsbad, CA, USA,
4309155) and 25 nM of each primer. QPCR reactions
were tripled and performed in ABI StepOnePlus system
through 50 cycles (15 sec at 95°C, 45 sec at 60°C). Ct
values were generated by ABI software. Standard errors
in Figure 4C were generated from six individual ChIP-qPCR experiments. Concentration of the ChIP samples
was calculated as percent of input. QPCR was performed
using primers for Oct4 promoter (forward, 5′-AGTGA
GAAGGGCAGGAGGAT-3′; reverse, 5′-CCTACTTGC
TCACACCACCA-3′), Nkx2.5 promoter (forward, 5′-
CCACCCCCAACCCTGCGTTT-3′; reverse, 5′-AGG
GGCCGCGACACATTTGG-3′), Chr4 site-1: 104,654,
835-104,654,965 (forward, 5′- CAACAACCAACCTA
GCTTTCCT-3′; reverse, 5′-GAGAGGATCGGTGG
GAGGTC-3′), Chr4 site-2: 104,668,986-104,669,071
(forward, 5′- TCTGAGGGGGTTGGCATAGA-3′; re-
verse, 5′-GATGTGTGCAAATGGGACCG-3′), Chr4
site-3: 104,693,231-104,693,309 (forward, 5′-TCCCT
TACGTCACCGTCTGA-3′; reverse, 5′-AAACACCT
TGACCAGAGGGC-3′), Chr 4 site-4: 104,713,676-
104,713,776 (forward, 5′-GTTGGCGCTTGTGAACT
GAG-3′; reverse, 5′-GTTAGGCAATGGCAGGAGG
T-3′), Chr7 site-1: 82,610,306-82,610,419 (forward, 5′-
TCCTCGGGAACCTACTCCAG-3′; reverse, 5′-TACA
GACACCGACTGAGGCT-3′), Chr7 site-2: 82,647,
473-82,647,844 (forward, 5′-GCTCGGGTCTCTGTG
TCTGTC-3′; reverse, 5′-CGGGTGGGAGAAAGTG
GAAGA-3′), Chr7 site-3: 82,660,145-82,660,243 (for-
ward, 5′-CTCTGCAGCCTGTAAGTGGT-3′; reverse,
5′-ATGTACCACCAGCACACCAG-3′), and Chr7 site-4:
82,662,755-82,662,863 (forward, 5′-CTGATGCCCTGTA
GTGCCTT-3′; reverse, 5′-TACAGGGTGGAGGTGGC
TTT-3′).
Immunostaining
ES cells grown on culture dishes were collected by trypsini-
zation, cytospun onto glass slides, fixed with 4% paraformal-
dehyde in PBS (10 min, 25°C), washed, and then
permeabilized with 0.5% Triton X-100 in PBS (10 min,
25°C). For immunostaining, the samples were incubated in
blocking solution (3% BSA, 0.1% Tween 20, 4 × SSC) for
30 min at 37°C to reduce nonspecific binding, and then in
detection solution containing primary antibodies (1% BSA,
0.1% Tween 20, 4 × SSC) for 1 h at 37°C. After three washes
with 4 × SSC, the samples were incubated in detection
solution containing secondary antibodies. For Nanog immu-
nostaining, cells were fixed with formalin/acetic acid and
then treated with methanol for 20 min at −20°C. The
primary antibodies were: anti-BAF250a mouse monoclonal
antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA,
sc-20701) diluted 1:50, anti-Oct4 mouse monoclonal anti-
body (BD Biosciences, San Jose, CA, USA, 611202) diluted
1:200, anti-Nanog rabbit polyclonal antibody (Chemicon,
Temecula, CA, USA, MAB3448) diluted 1:20. Alexa Fluor
488 goat anti-mouse IgG (Molecular Probes, Life Techno-
logies, Carlsbad, CA, USA, A11017) and Alexa Fluor 555
goat anti-rabbit IgG (Molecular Probes, Life Technologies,
Carlsbad, CA, USA, A21430) were the secondary antibodies.
Before imaging, the slides were counterstained with DAPI
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90% glycerol containing antifade reagent.
RNA FISH
RNA FISH was performed as described previously [43].
To generate RNA FISH probes, Rex1 genomic DNA
fragments were amplified, cloned into pBluscript, and
labeled by nick translation. Cells were treated with 0.5%
Triton X-100 in CSK buffer (100 mM NaCl, 300 mM
sucrose, 10 mM Pipes, pH 6.8, 3 mM MgCl2, 1 mM
EGTA) for 30 sec at 4°C, fixed with 4% paraformal-
dehyde, and then immersed in 70% ethanol for 5 min
at −20°C, dehydrated through a 90% and 100% ethanol
series, and the denatured FISH probe mixture was
hybridized to slides at 37°C for 16 h in a moist chamber.
Slides were washed three times with 50% formamide in
2X SSC at 43°C and three times with 0.8X SSC at 60°C.
Slides were then incubated for 30 min in a blocking
solution (3% BSA, 0.1% Tween 20 in 2X SSC) at 37°C
and incubated in a detection solution (in 1% BSA, 0.1%
Tween 20 in 2X SSC) containing anti-digoxigenin-
conjugated rhodamine (Roche, Nutley, New Jersey, USA,
11207750910) for 30 min at 37°C. Then slides were
washed three times with 4X SSC, 0.1% Tween 20 for 5 min
at 43°C. Before imaging, the slides were counterstained with
DAPI (200 ng/ml), washed with 4X SSC, and then mounted
in 90% glycerol containing antifade reagent.
Replication timing profiling by microarray
Replication timing analysis was performed as described
previously [6,7]. In brief, cells were labeled with 50 μM
BrdU for 2 h, washed twice with ice-cold PBS, trypsi-
nized, and then were fixed in 75% ethanol. These cells
were resuspended in PBS containing 1% FBS, stained
with propidium iodide (50 μg/ml) for 30 min in the
presence of RNaseA (0.5 mg/ml), and then were sorted
into early and late S phase fractions by flow cytometry.
After phenol-chloroform extraction of DNA, immuno-
precipitation with anti-BrdU mouse monoclonal anti-
body (BD Biosciences, San Jose, CA, USA, 555627) was
performed in each fraction to enrich BrdU-substituted
replicating DNA. Isolated early and late replicating DNA
were amplified by whole-genome amplification (WGA)
(Sigma-Aldrich, St Louis, MO, USA, GenomePlex), labeled
with Cy3 and Cy5, and hybridized to a mouse whole-
genome microarray (NimbleGen Symtems, Madison WIS,
USA, 2006-07-26_MM8_WG_CGH or 100718_MM9_
WG_CGH_HX3). Sample labeling, hybridization and
data extraction were performed according to stand-
ard NimbleGen Systems procedures. Data analyses
were performed using R/Bioconductor (http://www.r-
project.org; http://www.bioconductor.org). Obtained
raw datasets were normalized using the limma pack-
age in R/Bioconductor and loess-smoothed over a300-Kb window size. These smoothed datasets were
used to generate replication-timing plots in figures.
For some analyses, datasets were averaged into 200-Kb win-
dows (fixed position) and replication timing differential
(that is, OHT ratio - mock ratio) was determined for each
200-Kb segment. In order to determine the significant repli-
cation timing switching domains that are independent of
changes between replicates, we determined Euclidian dis-
tance at 10,974 200-Kb segments between groups (that is,
mock versus OHT) and within groups (that is, mock
replicate-1 versus mock replicate-2), which was used to
calculate P values at each 200-Kb genomic segment.
Statistical significance was then calculated using the qvalue
package in R/Bioconductor, which yields a q-value for each
segment that reflects the proportion of false-positives (False
Discovery Rate; FDR) among segments deemed to have sig-
nificant replication timing (RT) changes. High confidence
replication timing switching domains were selected with a
q-value cutoff of 0.01, corresponding to an overall FDR of
1%. A q-value cutoff of 0.05 was also used to identify a set
of lower confidence domains. To examine alignment of
timing switching domains to developmental domains, repli-
cation timing data from 9 cell types (ESC/iPSC, EBM3/
EPL, EBM6/EpiSC, NPC, Mesoderm, Endoderm, partial
iPSC, MEF, and Myoblast) were assembled from the Repli-
cationDomain.org database [44] and plotted together with
the data from BAF250a mock and OHT. Timing switching
domains from chromosome 1 (largest-sized) and chromo-
some 10 (middle-sized) were selected and their alignment
to developmental domains was judged by visual inspection
in Figure 1E. Indeed, when we examined statistical signifi-
cance of replication timing changes of BAF250a OHTcom-
pared to other cell lines, most domains examined in
Figure 1E were not significantly different from at least one
of nine cell types, even with a q-value cutoff of 0.2 (42/52
EtoL domains and 42/44 LtoE domains). The size of
switching domains was determined using a segmentation
algorithm in the DNAcopy package in R/Bioconductor as
described previously [6]. Unsmoothed datasets consisting
of replication timing (BAF250a OHT ratio - mock ratio)
for all probes were processed for switching domain
segmentation and the resultant EtoL and LtoE segment
sizes were shown in Figure 1F. Replication timing datasets
are downloadable from ReplicationDomain (http://www.
replicationdomain.org).Imaging system and measurement
Images were collected using a Nikon Ti-U Eclipse fluores-
cence microscope equipped with a 60x, 1.40 NA lens and a
cooled charge-coupled device camera (C4742-95-12ER,
Hamamatsu Photonics, Hamamatsu, Japan), controlled
by a windows computer running the software program
MetaMorph (Molecular Devices, Sunnyvale CA, USA).
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Additional file 1: Replication timing profile at chr15 (65.4-66.0 Mb)
domain. (A) TOP: The BAF250a protein level was monitored by
immunofluorescence staining at 0 (control), 24, and 72 h after
4-hydroxytamoxifen (OHT)-mediated induction of Cre recombinase.
Circled are the nuclei of feeder mouse embryonic fibroblasts (MEFs), in
which BAF250a protein level is not affected by the drug treatment, which
serves as an internal immunostaining control. Bars, 10 μm. BOTTOM:
Western blot showing protein levels of BAF250a with (OHT) and without
(Mock) Cre recombinase induction. (B) Replication timing profile of the
chr15 domain shown in Figure 1D from untreated, 24 h mock-treated
and 24 h OHT-treated embryonic stem cells (ESCs). Replication timing
change at this domain was not observed during the 24 h experimental period.
(C) Box plots show the replication timing of domains that are sensitive to
BAF250a loss (false discovery rate (FDR) = 1% from Figure 1C) after 24 h and
72 h of OHT treatment. (D) Responses to BAF250a loss are reproducible. Top
panels show average replication timing profile at the Chr15 domain.
Replication timing profiles from two independent experiments are shown
below. (E) P value calculation based on the global Euclidian distances
between groups and within replicates. Top plot is an examplary region
showing replication timing of BAF250 ESC OHT in dark and light blue, and
BAF250 ESC mock in dark and light grey. Bottom plot shows global Probability
Density Function (PDF) of Euclidian distance between groups (red) and within
replicates (grey) calculated from replication timing in individual probes. The
individual probes with significant replication timing differences are shown as
red lines in the top plot.
Additional file 2: BAF250a-deficient embryonic stem cells (ESCs) have
pluripotency-specific replication profiles. Replication timing profile of
Dppa2/4 and Rex1 domains derived from genome-wide analysis of various cell
types. These domains are known to show early replication in pluripotent cells,
but switch to late replication after differentiation [6].
Additional file 3: Pluripotency-associated marker expressions in
BAF250a-deficient embryonic stem cells (ESCs). (A) Immunofluorescence
analysis of Oct4 and Nanog proteins (left two panels) and RNA-FISH analysis of
Rex1 mRNA in mock- and 4-hydroxytamoxifen (OHT)-treated ESCs. Bars,
10 μm. (B) Western blot showing protein levels of Oct4. The results for the
loading control, tubulin, were the same as those in Additional file 1A. (C)
RT-PCR expression level validation for pluripotency-associated genes. *P <0.05;
nsP >0.1 (no significant difference). Statistical analysis was performed by a
two-tailed Student’s t-test.
Additional file 4: Characterization of conditional Brg1 and BAF53a
knockout. Western blot showing protein levels of Brg1, BAF53a, and Oct4
after 4-hydroxytamoxifen (OHT)-mediated Cre recombinase induction.
Additional file 5: Replication domains that are commonly
dysregulated both in BAF250a and Brg1 mutants. Venn diagrams
show the overlap between domains that undergoes early to late (EtoL)
switching (left) and late to early (LtoE) switching (right) upon BAF250a
loss in embryonic stem cells (ESCs) versus Oct4, Sox2, Klf4, and c-Myc
(OSKM) cells (false discovery rate (FDR) = 1% from Figure 1C and Figure
2F), as compared to Brg1-affected EtoL and LtoE segments (FDR = 1%
from Figure 3D). Since the total number of affected segments is small,
the overlap between BAF250a-affected EtoL segments and Brg1-affected
EtoL segments is highly significant relative to what would be expected
for a random distribution (P <0.001). However, limited overlaps between
these segments may also suggest the existence of subunit-specific roles
in replication timing regulation.
Additional file 6: Replication timing of the Oct4 domain. Replication
timing profile of the Oct4 domain derived from genome-wide analysis of
various cell types. The domain is early replicating before and after
esBAF complex deficiency. Thirty seven Brg1 binding sites were identified by
chromatin immunoprecipitation (ChIP)-seq [35] within the domain.Abbreviations
BAF: Brg1/Brm associated factors; Brg1: Brahma-related gene 1;
ChIP: Chromatin immunoprecipitation; ES cell: Embryonic stem cell;
EtoL: Early to late; dRT: Replication timing differences; FDR: False discovery
rate; GFP: Green fluorescent protein; iPSC: Induced pluripotent stem cells;KD: Knockdown; LtoE: Late to early; OHT: 4-hydroxytamoxifen; MEFs: Mouse
embryonic fibroblasts; OSKM: Oct4, Sox2, Klf4, and c-Myc; RT: Replication
timing.
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